Indeed, although some proinflammatory cytokines are known to increase expression of ACKR2 (although notably not the psoriasis-associated cytokine IL-17 (16, 24)), little is known about the molecular mechanisms that control atypical chemokine receptor expression. This evidence concerns the gene ACKR2 and psoriasis.